文献速递血管炎

不同感染谱与ANCA相关血管炎一年结局的关联:一项每月感染筛查的回顾性研究

Association between different infection profiles and one-year outcomes in ANCA-associated vasculitis: a retrospective study with monthly infection screening.
PubMed 文献 · RMD Open · 2022-01-01

该回顾性研究纳入2000至2018年上海瑞金医院肾脏科415例新诊断ANCA相关血管炎患者,诊断后前3个月每月筛查感染。220例患者共发生377次感染,1年总生存率73.0%;感染与1年死亡独立相关(校正HR 2.32,95%CI 1.27至4.23,p=0.006),呼吸道感染、革兰阴性菌感染和真菌感染为1年死亡危险因素,复方磺胺甲噁唑预防为保护因素。

要点

  • 诊断后前3个月220例患者发生377次感染,呼吸道感染210次/164人,占感染一半以上。
  • 感染与1年死亡独立相关,校正HR 2.32(95%CI 1.27至4.23,p=0.006)。
  • 复方磺胺甲噁唑预防与1年死亡风险降低相关,校正HR 0.55(95%CI 0.31至0.97,p=0.040)。

核心结论

  • 感染尤其是呼吸道感染是ANCA相关血管炎患者常见且重要的并发症,与早期死亡相关;复方磺胺甲噁唑预防可能有必要以改善短期结局,应更多考虑感染风险并定期筛查感染。

研究设计与样本

  • 回顾性研究,纳入2000至2018年上海瑞金医院肾脏科415例新诊断ANCA相关血管炎患者,诊断后前3个月每月进行感染筛查,采用4个Cox回归模型分析。

主要发现

  • 前3个月220例患者共发生377次感染,呼吸道感染210次/164人,占感染一半以上。
  • 1年总生存率为73.0%。
  • 感染与1年死亡独立相关(校正HR 2.32,95%CI 1.27至4.23,p=0.006)。
  • 呼吸道感染(校正HR 4.36,95%CI 2.86至8.06,p<0.001)、革兰阴性菌感染(校正HR 1.71,95%CI 1.01至2.91,p=0.047)和真菌感染(校正HR 1.77,95%CI 1.07至2.94,p=0.026)为1年死亡危险因素。
  • 复方磺胺甲噁唑预防对1年死亡为保护因素(校正HR 0.55,95%CI 0.31至0.97,p=0.040)。

关键数值与推荐

  • 感染与1年死亡独立相关:校正HR 2.32(95%CI 1.27至4.23,p=0.006)。
  • 呼吸道感染与1年死亡相关:校正HR 4.36(95%CI 2.86至8.06,p<0.001)。
  • 革兰阴性菌感染与1年死亡相关:校正HR 1.71(95%CI 1.01至2.91,p=0.047)。
  • 真菌感染与1年死亡相关:校正HR 1.77(95%CI 1.07至2.94,p=0.026)。
  • 复方磺胺甲噁唑预防与1年死亡相关:校正HR 0.55(95%CI 0.31至0.97,p=0.040)。

临床怎么用

  • 作者认为复方磺胺甲噁唑预防可能有必要以改善短期结局。
  • 作者认为应更多考虑感染风险并定期筛查感染。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to explore clinical features of early infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to identify the association between the infection profile of patients with AAV during the first 3 months and 1-year survival. METHODS: A total of 415 newly diagnosed patients with AAV in the Department of Nephrology at Shanghai Ruijin Hospital from 2000 to 2018 were included. Four Cox regression models were used to analyse the association based on demographics, comorbidities, laboratory baseline index and therapy parameter. Infection screening was carried out monthly during the first 3 months after diagnosis. RESULTS: In all, 377 episodes of infection were identified among 220 patients during the first 3 months. The overall survival after 1 year was 73.0%. Respiratory infection (210 episodes/164 persons) accounted for more than half of infections. Infection was independently associated with 1-year mortality (adjusted HR 2.32, 95% CI 1.27 to 4.23, p=0.006) after adjustment. Respiratory infection (adjusted HR 4.36, 95% CI 2.86 to 8.06, p<0.001), Gram-negative bacterial infection (adjusted HR 1.71, 95% CI 1.01 to 2.91, p=0.047) and fungal infection (adjusted HR 1.77, 95% CI 1.07 to 2.94, p=0.026) was identified as a risk factor for 1-year mortality. Trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis (adjusted HR 0.55, 95% CI 0.31 to 0.97, p=0.040) was protective for 1-year mortality. CONCLUSIONS: Infections, particularly respiratory infections, are a common and important class of complication in patients with AAV and are associated with early mortality. TMP-SMX prophylaxis might be necessary to improve short-term outcome. More consideration of infectious risk and regular infection screening should be given.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Xu T, Chen Z, Jiang M, et al. Association between different infection profiles and one-year outcomes in ANCA-associated vasculitis: a retrospective study with monthly infection screening. RMD Open. 2022. PMID: 36270741. doi:10.1136/rmdopen-2022-002424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。